Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
2004 1
2009 3
2010 1
2011 1
2012 1
2013 1
2014 4
2015 3
2016 3
2017 1
2018 1
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
CALR mutation profile in Irish patients with myeloproliferative neoplasms.
Haslam K, Conneally E, Flynn CM, Cahill MR, Gilligan O, O'Shea D, Langabeer SE. Haslam K, et al. Among authors: gilligan o. Hematol Oncol Stem Cell Ther. 2016 Sep;9(3):112-5. doi: 10.1016/j.hemonc.2016.05.002. Epub 2016 Jun 23. Hematol Oncol Stem Cell Ther. 2016. PMID: 27352261 Free article.
Screening for CRLF2 overexpression in adult acute lymphoblastic leukemia.
Haslam K, Kelly J, Morris T, Connaghan G, Gilligan O, Browne P, Langabeer SE. Haslam K, et al. Among authors: gilligan o. Int J Lab Hematol. 2011 Dec;33(6):e17-9. doi: 10.1111/j.1751-553X.2011.01319.x. Epub 2011 Apr 4. Int J Lab Hematol. 2011. PMID: 21457190 No abstract available.
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
O'Gorman P, Laubach JP, O'Dwyer ME, Krawczyk J, Yee AJ, Gilligan O, Cahill MR, Rosenblatt J, Quinn J, Murphy PT, DiPietro H, Perera MR, Crotty GM, Cummings K, Hayden PJ, Browne P, Savell A, O'Leary HM, O'Keeffe D, Masone K, Hennessy BJ, Guerrero Garcia T, Scott K, Saeed K, Bianchi G, Dowling P, Tierney C, Richardson PG. O'Gorman P, et al. Among authors: gilligan o. Am J Hematol. 2022 May;97(5):562-573. doi: 10.1002/ajh.26491. Epub 2022 Feb 18. Am J Hematol. 2022. PMID: 35132679 Clinical Trial.
22 results